首页 > 最新文献

Archives of dermatology最新文献

英文 中文
Successful treatment of bullous pemphigoid with omalizumab. omalizumab成功治疗大疱性类天疱疮。
Pub Date : 2012-11-01 DOI: 10.1001/archdermatol.2012.1604
Vanessa A London, Gene H Kim, Janet A Fairley, David T Woodley
Bullous pemphigoid (BP) is an acquired, autoimmune, bullous disease that is characterized by autoantibodies against the 230-kDa bullous pemphigoid antigen within basal keratinocytes and the 180-kDa type XVII collagen within the basement membrane zone (BMZ) lying between the epidermis and dermis. In addition to skin blisters, patients with BP often experience pruritus and erythematous urticaria-like skin lesions. IgG is usually the predominant autoantibody in the plasma and skin of patients with BP. Nevertheless, most of these patients also have IgE autoantibodies against type XVII collagen, and these IgE autoantibodies have been shown to be pathogenic. Herein, we report a case of a woman with pruritic BP and very high levels of IgE and eosinophils who was refractory to standard aggressive immunosuppressive regimens for BP but responded rapidly to systemic omalizumab, a biological agent that binds to and nullifies IgE.
{"title":"Successful treatment of bullous pemphigoid with omalizumab.","authors":"Vanessa A London, Gene H Kim, Janet A Fairley, David T Woodley","doi":"10.1001/archdermatol.2012.1604","DOIUrl":"https://doi.org/10.1001/archdermatol.2012.1604","url":null,"abstract":"Bullous pemphigoid (BP) is an acquired, autoimmune, bullous disease that is characterized by autoantibodies against the 230-kDa bullous pemphigoid antigen within basal keratinocytes and the 180-kDa type XVII collagen within the basement membrane zone (BMZ) lying between the epidermis and dermis. In addition to skin blisters, patients with BP often experience pruritus and erythematous urticaria-like skin lesions. IgG is usually the predominant autoantibody in the plasma and skin of patients with BP. Nevertheless, most of these patients also have IgE autoantibodies against type XVII collagen, and these IgE autoantibodies have been shown to be pathogenic. Herein, we report a case of a woman with pruritic BP and very high levels of IgE and eosinophils who was refractory to standard aggressive immunosuppressive regimens for BP but responded rapidly to systemic omalizumab, a biological agent that binds to and nullifies IgE.","PeriodicalId":8175,"journal":{"name":"Archives of dermatology","volume":"148 11","pages":"1241-3"},"PeriodicalIF":0.0,"publicationDate":"2012-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1001/archdermatol.2012.1604","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"31060760","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 66
The Person-Centered Dermatology Self-Care Index: a tool to measure education and support needs of patients with long-term skin conditions. 以人为中心的皮肤病学自我保健指数:一个工具,以衡量教育和支持需要的长期皮肤病患者。
Pub Date : 2012-11-01 DOI: 10.1001/archdermatol.2012.1892
Fiona Cowdell, Steven J Ersser, Coleen Gradwell, Peter W Thomas

Objective: To validate the Person-Centered Dermatology Self-Care Index (PeDeSI) as a tool for clinical assessment and for potential use in research evaluation.

Design: To date, no validated assessment measures exist to identify the education and support needs of patients living with long-term dermatological conditions and to enable them to self-manage as effectively as possible. The PeDeSI assessment tool was developed to meet this need using the self-efficacy construct and a model of concordance within prescribing practice. In total, 200 copies of the PeDeSI were distributed for validation, and 145 (72.5%) were returned completed. Data were analyzed using statistical software. Frequency distributions of all items were examined, and internal consistency was summarized using Cronbach α. Exploratory factor analysis was used to disclose any underlying structure among the data items. SETTING Three specialist dermatology centers in acute care hospitals.

Participants: Dermatology specialist nurses treating patients with chronic dermatoses.

Intervention: A PeDeSI was completed with each patient during his or her usual outpatient consultation.

Main outcome measure: Cronbach α.

Results: Cronbach α was 0.90, indicating good internal consistency. Eliminating individual items in turn made little difference in Cronbach α (range, 0.89-0.90). Item total correlations ranged from 0.44 to 0.76 (median, 0.68). Exploratory factor analysis extracted just one factor (eigenvalue, 5.37), with no other factors having eigenvalues exceeding 1.00. Factor loadings on individual items ranged from 0.47 to 0.80. CONCLUSION The PeDeSI is a valid, reliable, and clinically practical tool to systematically assess the education and support needs of patients with long-term dermatological conditions and to promote treatment concordance.

目的:验证以人为中心的皮肤病学自我护理指数(PeDeSI)作为临床评估和研究评估的潜在工具。设计:到目前为止,还没有有效的评估措施来确定长期皮肤病患者的教育和支持需求,并使他们能够尽可能有效地自我管理。PeDeSI评估工具是为了满足这一需求而开发的,使用自我效能结构和处方实践中的一致性模型。总共分发了200份PeDeSI用于验证,145份(72.5%)完成返回。采用统计软件对数据进行分析。检查所有项目的频率分布,并使用Cronbach α来总结内部一致性。探索性因子分析用于揭示数据项之间的潜在结构。三个专科皮肤科中心在急症护理医院。参与者:皮肤科专科护士治疗慢性皮肤病患者。干预措施:在每位患者的常规门诊会诊期间完成PeDeSI。主要结局指标:Cronbach α。结果:Cronbach α为0.90,内部一致性较好。依次消除个别项目对Cronbach α的影响不大(范围0.89-0.90)。项目总相关性范围为0.44 ~ 0.76(中位数0.68)。探索性因子分析只提取了一个因子(特征值,5.37),没有其他因子的特征值超过1.00。个别项目的因子负荷从0.47到0.80不等。结论PeDeSI是一种有效、可靠、临床实用的工具,可以系统地评估长期皮肤病患者的教育和支持需求,促进治疗的一致性。
{"title":"The Person-Centered Dermatology Self-Care Index: a tool to measure education and support needs of patients with long-term skin conditions.","authors":"Fiona Cowdell,&nbsp;Steven J Ersser,&nbsp;Coleen Gradwell,&nbsp;Peter W Thomas","doi":"10.1001/archdermatol.2012.1892","DOIUrl":"https://doi.org/10.1001/archdermatol.2012.1892","url":null,"abstract":"<p><strong>Objective: </strong>To validate the Person-Centered Dermatology Self-Care Index (PeDeSI) as a tool for clinical assessment and for potential use in research evaluation.</p><p><strong>Design: </strong>To date, no validated assessment measures exist to identify the education and support needs of patients living with long-term dermatological conditions and to enable them to self-manage as effectively as possible. The PeDeSI assessment tool was developed to meet this need using the self-efficacy construct and a model of concordance within prescribing practice. In total, 200 copies of the PeDeSI were distributed for validation, and 145 (72.5%) were returned completed. Data were analyzed using statistical software. Frequency distributions of all items were examined, and internal consistency was summarized using Cronbach α. Exploratory factor analysis was used to disclose any underlying structure among the data items. SETTING Three specialist dermatology centers in acute care hospitals.</p><p><strong>Participants: </strong>Dermatology specialist nurses treating patients with chronic dermatoses.</p><p><strong>Intervention: </strong>A PeDeSI was completed with each patient during his or her usual outpatient consultation.</p><p><strong>Main outcome measure: </strong>Cronbach α.</p><p><strong>Results: </strong>Cronbach α was 0.90, indicating good internal consistency. Eliminating individual items in turn made little difference in Cronbach α (range, 0.89-0.90). Item total correlations ranged from 0.44 to 0.76 (median, 0.68). Exploratory factor analysis extracted just one factor (eigenvalue, 5.37), with no other factors having eigenvalues exceeding 1.00. Factor loadings on individual items ranged from 0.47 to 0.80. CONCLUSION The PeDeSI is a valid, reliable, and clinically practical tool to systematically assess the education and support needs of patients with long-term dermatological conditions and to promote treatment concordance.</p>","PeriodicalId":8175,"journal":{"name":"Archives of dermatology","volume":"148 11","pages":"1251-5"},"PeriodicalIF":0.0,"publicationDate":"2012-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1001/archdermatol.2012.1892","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"31060761","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
Neutrophilic and eosinophilic dermatitis caused by contact allergic reaction to paraphenylenediamine in hair dye. 染发剂中对苯二胺的接触性过敏反应引起嗜中性粒细胞和嗜酸性皮炎。
Pub Date : 2012-11-01 DOI: 10.1001/archdermatol.2012.2586
Vincent Lönngren, Ewa Young, Mecius Simanaitis, Cecilia Svedman

Background: Paraphenylenediamine (PPD) in hair dyes can cause systemic as well as cutaneous allergic reactions such as neutrophilic and eosinophilic dermatitis. The symptoms are often severe. The acute lesion is normally histologically indistinguishable from any eczematous reaction with marked spongiosis.

Observations: We report a case of allergic contact dermatitis caused by the use of hair dye containing PPD that developed in a patient who had been using the same hair dye for many years. Her symptoms included scalp dermatitis and widespread skin lesions as well as lymphadenopathy and quite possibly dyspnea resembling asthma. What is most remarkable about this case is the histopathologic finding of neutrophilic cellulitis and a marked neutrophilic infiltrate with variable spongiosis. This unique finding was confirmed by histologic analysis of a patch test lesion specimen.

Conclusion: It is always important to consider contact allergic dermatitis as a cause of dermatitis because of the variable presentation of the disease, including unique histologic findings that do not fit the conventional picture, as in the present case.

背景:染发剂中的对苯二胺(PPD)可引起全身和皮肤过敏反应,如嗜中性粒细胞和嗜酸性皮炎。症状通常很严重。急性病变在组织学上通常与任何伴有明显海绵状病变的湿疹反应难以区分。观察:我们报告了一例过敏性接触性皮炎,由使用含有PPD的染发剂引起,该染发剂发生在一位使用同一种染发剂多年的患者身上。她的症状包括头皮皮炎和广泛的皮肤病变,以及淋巴结病,很可能有类似哮喘的呼吸困难。本病例最值得注意的是组织病理学发现中性粒细胞蜂窝组织炎和明显的中性粒细胞浸润伴变异性海绵状病变。这一独特的发现被斑贴试验病变标本的组织学分析证实。结论:考虑接触性过敏性皮炎是皮炎的一个原因是很重要的,因为这种疾病的表现是可变的,包括独特的组织学表现,不符合传统的图像,就像本病例一样。
{"title":"Neutrophilic and eosinophilic dermatitis caused by contact allergic reaction to paraphenylenediamine in hair dye.","authors":"Vincent Lönngren,&nbsp;Ewa Young,&nbsp;Mecius Simanaitis,&nbsp;Cecilia Svedman","doi":"10.1001/archdermatol.2012.2586","DOIUrl":"https://doi.org/10.1001/archdermatol.2012.2586","url":null,"abstract":"<p><strong>Background: </strong>Paraphenylenediamine (PPD) in hair dyes can cause systemic as well as cutaneous allergic reactions such as neutrophilic and eosinophilic dermatitis. The symptoms are often severe. The acute lesion is normally histologically indistinguishable from any eczematous reaction with marked spongiosis.</p><p><strong>Observations: </strong>We report a case of allergic contact dermatitis caused by the use of hair dye containing PPD that developed in a patient who had been using the same hair dye for many years. Her symptoms included scalp dermatitis and widespread skin lesions as well as lymphadenopathy and quite possibly dyspnea resembling asthma. What is most remarkable about this case is the histopathologic finding of neutrophilic cellulitis and a marked neutrophilic infiltrate with variable spongiosis. This unique finding was confirmed by histologic analysis of a patch test lesion specimen.</p><p><strong>Conclusion: </strong>It is always important to consider contact allergic dermatitis as a cause of dermatitis because of the variable presentation of the disease, including unique histologic findings that do not fit the conventional picture, as in the present case.</p>","PeriodicalId":8175,"journal":{"name":"Archives of dermatology","volume":"148 11","pages":"1299-301"},"PeriodicalIF":0.0,"publicationDate":"2012-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1001/archdermatol.2012.2586","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"31060766","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 15
Association between tumor necrosis factor inhibitor therapy and myocardial infarction risk in patients with psoriasis. 银屑病患者肿瘤坏死因子抑制剂治疗与心肌梗死风险的关系
Pub Date : 2012-11-01 DOI: 10.1001/archdermatol.2012.2502
Jashin J Wu, Kwun-Yee T Poon, Jennifer C Channual, Albert Yuh-Jer Shen

OBJECTIVE To assess whether patients with psoriasis treated with tumor necrosis factor (TNF) inhibitors have a decreased risk of myocardial infarction (MI) compared with those not treated with TNF inhibitors. DESIGN Retrospective cohort study. SETTING Kaiser Permanente Southern California health plan. PATIENTS Patients with at least 3 International Classification of Diseases, Ninth Revision, Clinical Modification, codes for psoriasis (696.1) or psoriatic arthritis (696.0) (without antecedent MI) between January 1, 2004, and November 30, 2010. MAIN OUTCOME MEASURE Incident MI. RESULTS Of 8845 patients included, 1673 received a TNF inhibitor for at least 2 months (TNF inhibitor cohort), 2097 were TNF inhibitor naive and received other systemic agents or phototherapy (oral/phototherapy cohort), and 5075 were not treated with TNF inhibitors, other systemic therapies, or phototherapy (topical cohort). The median duration of follow-up was 4.3 years (interquartile range, 2.9, 5.5 years), and the median duration of TNF inhibitor therapy was 685 days (interquartile range, 215, 1312 days). After adjusting for MI risk factors, the TNF inhibitor cohort had a significantly lower hazard of MI compared with the topical cohort (adjusted hazard ratio, 0.50; 95% CI, 0.32-0.79). The incidence of MI in the TNF inhibitor, oral/phototherapy, and topical cohorts were 3.05, 3.85, and 6.73 per 1000 patient-years, respectively. CONCLUSIONS Use of TNF inhibitors for psoriasis was associated with a significant reduction in MI risk and incident rate compared with treatment with topical agents. Use of TNF inhibitors for psoriasis was associated with a non-statistically significant lower MI incident rate compared with treatment with oral agents/phototherapy.

目的:评估银屑病患者接受肿瘤坏死因子(TNF)抑制剂治疗是否比未接受TNF抑制剂治疗的患者心肌梗死(MI)风险降低。设计回顾性队列研究。制定凯泽医疗保险公司南加州医疗计划。患者在2004年1月1日至2010年11月30日期间,至少患有3种国际疾病分类第九版临床修改银屑病(696.1)或银屑病关节炎(696.0)(无既往MI)的患者。纳入的8845例患者中,1673例患者接受TNF抑制剂治疗至少2个月(TNF抑制剂队列),2097例患者未接受TNF抑制剂治疗并接受其他全身药物或光疗(口服/光疗队列),5075例患者未接受TNF抑制剂、其他全身疗法或光疗(局部队列)。中位随访时间为4.3年(四分位数范围,2.9年,5.5年),TNF抑制剂治疗的中位持续时间为685天(四分位数范围,215天,1312天)。在校正心肌梗死危险因素后,TNF抑制剂组的心肌梗死风险明显低于局部组(校正风险比,0.50;95% ci, 0.32-0.79)。TNF抑制剂组、口服/光疗组和局部用药组的心肌梗死发生率分别为3.05、3.85和6.73 / 1000患者-年。结论:与外用药物治疗相比,使用TNF抑制剂治疗牛皮癣可显著降低心肌梗死风险和发生率。与口服药物/光疗治疗相比,使用TNF抑制剂治疗牛皮癣与心肌梗死发生率降低相关,无统计学意义。
{"title":"Association between tumor necrosis factor inhibitor therapy and myocardial infarction risk in patients with psoriasis.","authors":"Jashin J Wu,&nbsp;Kwun-Yee T Poon,&nbsp;Jennifer C Channual,&nbsp;Albert Yuh-Jer Shen","doi":"10.1001/archdermatol.2012.2502","DOIUrl":"https://doi.org/10.1001/archdermatol.2012.2502","url":null,"abstract":"<p><p>OBJECTIVE To assess whether patients with psoriasis treated with tumor necrosis factor (TNF) inhibitors have a decreased risk of myocardial infarction (MI) compared with those not treated with TNF inhibitors. DESIGN Retrospective cohort study. SETTING Kaiser Permanente Southern California health plan. PATIENTS Patients with at least 3 International Classification of Diseases, Ninth Revision, Clinical Modification, codes for psoriasis (696.1) or psoriatic arthritis (696.0) (without antecedent MI) between January 1, 2004, and November 30, 2010. MAIN OUTCOME MEASURE Incident MI. RESULTS Of 8845 patients included, 1673 received a TNF inhibitor for at least 2 months (TNF inhibitor cohort), 2097 were TNF inhibitor naive and received other systemic agents or phototherapy (oral/phototherapy cohort), and 5075 were not treated with TNF inhibitors, other systemic therapies, or phototherapy (topical cohort). The median duration of follow-up was 4.3 years (interquartile range, 2.9, 5.5 years), and the median duration of TNF inhibitor therapy was 685 days (interquartile range, 215, 1312 days). After adjusting for MI risk factors, the TNF inhibitor cohort had a significantly lower hazard of MI compared with the topical cohort (adjusted hazard ratio, 0.50; 95% CI, 0.32-0.79). The incidence of MI in the TNF inhibitor, oral/phototherapy, and topical cohorts were 3.05, 3.85, and 6.73 per 1000 patient-years, respectively. CONCLUSIONS Use of TNF inhibitors for psoriasis was associated with a significant reduction in MI risk and incident rate compared with treatment with topical agents. Use of TNF inhibitors for psoriasis was associated with a non-statistically significant lower MI incident rate compared with treatment with oral agents/phototherapy.</p>","PeriodicalId":8175,"journal":{"name":"Archives of dermatology","volume":"148 11","pages":"1244-50"},"PeriodicalIF":0.0,"publicationDate":"2012-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1001/archdermatol.2012.2502","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"30849548","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 277
Farewell to skINsight: Comment on “Rorschach Dermoscopy” 告别skininsight:评“罗夏皮肤镜”
Pub Date : 2012-11-01 DOI: 10.1001/ARCHDERMATOL.2012.2714
June K. Robinson, J. Callen
{"title":"Farewell to skINsight: Comment on “Rorschach Dermoscopy”","authors":"June K. Robinson, J. Callen","doi":"10.1001/ARCHDERMATOL.2012.2714","DOIUrl":"https://doi.org/10.1001/ARCHDERMATOL.2012.2714","url":null,"abstract":"","PeriodicalId":8175,"journal":{"name":"Archives of dermatology","volume":"33 2","pages":"1342-1342"},"PeriodicalIF":0.0,"publicationDate":"2012-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1001/ARCHDERMATOL.2012.2714","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"50616938","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Peripheral lymph node recurrence of tuberculosis after ustekinumab treatment. ustekinumab治疗后结核周围淋巴结复发。
Pub Date : 2012-11-01 DOI: 10.1001/archdermatol.2012.2958
Ana I Sánchez-Moya, Esteban Daudén
{"title":"Peripheral lymph node recurrence of tuberculosis after ustekinumab treatment.","authors":"Ana I Sánchez-Moya,&nbsp;Esteban Daudén","doi":"10.1001/archdermatol.2012.2958","DOIUrl":"https://doi.org/10.1001/archdermatol.2012.2958","url":null,"abstract":"","PeriodicalId":8175,"journal":{"name":"Archives of dermatology","volume":"148 11","pages":"1332-3"},"PeriodicalIF":0.0,"publicationDate":"2012-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1001/archdermatol.2012.2958","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"31060167","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 13
Top Accessed Article: Propionibacterium Acnes and the Pathogenesis of Progressive Macular Hypomelanosis 热门文章:痤疮丙酸杆菌和进行性黄斑低黑症的发病机制
Pub Date : 2012-11-01 DOI: 10.1001/ARCHDERMATOL.2012.2177
Amit G. Pandya
Author Affiliations: Center for Dermatology Research, Department of Dermatology, Wake Forest School of Medicine, Winston-Salem, North Carolina. Correspondence: Dr Feldman, Center for Dermatology Research, Department of Dermatology, Wake Forest University School of Medicine, Medical Center Boulevard, Winston-Salem, NC 27157 (sfeldman@wakehealth .edu). Conflict of InterestDisclosures: Dr Feldman has received research,speaking,orconsultingsupport fromvariouscompanies, including Galderma Laboratories LP, GSK/Stiefel, Medicis,Valeant,Abbott,Amgen,Astellas, Janssen,National BiologicalCorporation,NationalPsoriasisFoundation,and Novartis, and is an owner of DrScore.com (http://www .Dr.Score.com), a patient satisfaction survey company. Funding/Support: The Center for Dermatology Research is funded by a grant from Galderma Laboratories LP.
作者单位:北卡罗莱纳温斯顿-塞勒姆维克森林医学院皮肤科皮肤病研究中心。通信:费尔德曼博士,皮肤病学研究中心,皮肤学系,维克森林大学医学院,医学中心大道,温斯顿-塞勒姆,北卡罗莱纳州27157 (sfeldman@wakehealth .edu)。利益冲突披露:Feldman博士接受了来自多家公司的研究、演讲或咨询支持,包括Galderma Laboratories LP、GSK/Stiefel、Medicis、Valeant、Abbott、Amgen、Astellas、Janssen、National BiologicalCorporation、National psoriasisfoundation和Novartis,他还是一家患者满意度调查公司DrScore.com (http://www .Dr. score.com)的所有者。资助/支持:皮肤病学研究中心由Galderma Laboratories LP资助。
{"title":"Top Accessed Article: Propionibacterium Acnes and the Pathogenesis of Progressive Macular Hypomelanosis","authors":"Amit G. Pandya","doi":"10.1001/ARCHDERMATOL.2012.2177","DOIUrl":"https://doi.org/10.1001/ARCHDERMATOL.2012.2177","url":null,"abstract":"Author Affiliations: Center for Dermatology Research, Department of Dermatology, Wake Forest School of Medicine, Winston-Salem, North Carolina. Correspondence: Dr Feldman, Center for Dermatology Research, Department of Dermatology, Wake Forest University School of Medicine, Medical Center Boulevard, Winston-Salem, NC 27157 (sfeldman@wakehealth .edu). Conflict of InterestDisclosures: Dr Feldman has received research,speaking,orconsultingsupport fromvariouscompanies, including Galderma Laboratories LP, GSK/Stiefel, Medicis,Valeant,Abbott,Amgen,Astellas, Janssen,National BiologicalCorporation,NationalPsoriasisFoundation,and Novartis, and is an owner of DrScore.com (http://www .Dr.Score.com), a patient satisfaction survey company. Funding/Support: The Center for Dermatology Research is funded by a grant from Galderma Laboratories LP.","PeriodicalId":8175,"journal":{"name":"Archives of dermatology","volume":"33 9","pages":"1256-1256"},"PeriodicalIF":0.0,"publicationDate":"2012-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1001/ARCHDERMATOL.2012.2177","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"50616894","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 81
Atomic Bomb Lexicon 原子弹词典
Pub Date : 2012-11-01 DOI: 10.1001/ARCHDERMATOL.2012.3129
L. Hoenig
{"title":"Atomic Bomb Lexicon","authors":"L. Hoenig","doi":"10.1001/ARCHDERMATOL.2012.3129","DOIUrl":"https://doi.org/10.1001/ARCHDERMATOL.2012.3129","url":null,"abstract":"","PeriodicalId":8175,"journal":{"name":"Archives of dermatology","volume":"32 9","pages":"1298-1298"},"PeriodicalIF":0.0,"publicationDate":"2012-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1001/ARCHDERMATOL.2012.3129","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"50616943","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Ablative fractional resurfacing for involuted hemangioma residuum. 受累血管瘤残余的消融分次表面修复。
Pub Date : 2012-11-01 DOI: 10.1001/archdermatol.2012.2346
Lori A Brightman, Jeremy A Brauer, Vitaly Terushkin, Christopher Hunzeker, Kavitha K Reddy, Elliot T Weiss, Julie K Karen, Elizabeth K Hale, Robert Anolik, Leonard Bernstein, Roy G Geronemus

BACKGROUND Given the natural tendency for 15% to 40% of infantile hemangiomas to spontaneously involute over time, much debate surrounds the issue of treatment. Until recently, effective therapies to improve the appearance of residual textural skin changes in these patients were lacking. We suggest the use of ablative fractional resurfacing for the treatment of textural skin changes resulting from involuted hemangiomas. OBSERVATIONS All patients treated with an ablative fractional carbon dioxide laser experienced considerable flattening of the fibrofatty residual tissue, with at least 50% to 75% improvement in color, texture, and overall appearance. CONCLUSION While additional future studies are needed, we believe that ablative fractional resurfacing should be considered for the treatment of textural skin changes associated with involuted infantile hemangiomas.

背景:考虑到15% - 40%的婴儿血管瘤随时间自然发展的趋势,围绕治疗问题有很多争论。直到最近,还缺乏有效的治疗方法来改善这些患者残留的皮肤质地变化的外观。我们建议使用烧蚀分次表面重塑治疗皮肤质地的变化,导致纠缠的血管瘤。所有接受消融二氧化碳激光治疗的患者都经历了相当大的纤维脂肪残余组织变平,在颜色、质地和整体外观上至少有50%至75%的改善。结论:虽然还需要进一步的研究,但我们认为,对于与受卷型婴儿血管瘤相关的皮肤质地改变,应考虑行消融分次表面修复。
{"title":"Ablative fractional resurfacing for involuted hemangioma residuum.","authors":"Lori A Brightman,&nbsp;Jeremy A Brauer,&nbsp;Vitaly Terushkin,&nbsp;Christopher Hunzeker,&nbsp;Kavitha K Reddy,&nbsp;Elliot T Weiss,&nbsp;Julie K Karen,&nbsp;Elizabeth K Hale,&nbsp;Robert Anolik,&nbsp;Leonard Bernstein,&nbsp;Roy G Geronemus","doi":"10.1001/archdermatol.2012.2346","DOIUrl":"https://doi.org/10.1001/archdermatol.2012.2346","url":null,"abstract":"<p><p>BACKGROUND Given the natural tendency for 15% to 40% of infantile hemangiomas to spontaneously involute over time, much debate surrounds the issue of treatment. Until recently, effective therapies to improve the appearance of residual textural skin changes in these patients were lacking. We suggest the use of ablative fractional resurfacing for the treatment of textural skin changes resulting from involuted hemangiomas. OBSERVATIONS All patients treated with an ablative fractional carbon dioxide laser experienced considerable flattening of the fibrofatty residual tissue, with at least 50% to 75% improvement in color, texture, and overall appearance. CONCLUSION While additional future studies are needed, we believe that ablative fractional resurfacing should be considered for the treatment of textural skin changes associated with involuted infantile hemangiomas.</p>","PeriodicalId":8175,"journal":{"name":"Archives of dermatology","volume":"148 11","pages":"1294-8"},"PeriodicalIF":0.0,"publicationDate":"2012-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1001/archdermatol.2012.2346","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"30849809","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 25
Fleshy papules in areas of friction in a man with endocrine neoplasms. 内分泌肿瘤患者摩擦部位的肉质丘疹。
Pub Date : 2012-11-01 DOI: 10.1001/archdermatol.2012.2277b
Jennifer Walker, Victoria Raymond, Lori Lowe, Kelly B Cha
A 39-year-old African American man presented with a progressive eruption of fleshy papules on his neck, axillae, groin, and abdomen. The lesions first developed on his neck in his mid-20s and slowly progressed to involve other sites. They occasionally bled when traumatized. His more recent medical history was remarkable for multigland parathyroid hyperplasia, pituitary microadenoma, and neuroendocrine pancreatic tumors. Physical examination revealed dozens of 2to 10mm, flesh-colored to brown, pedunculated, verrucous papules located circumferentially around the neck (Figure 1), extending down to the anterior aspect of the chest, and in the axillae and bilateral groin folds. Scattered across the lower area of the abdomen, there were numerous hypopigmented to flesh-colored 4to 10-mm dome-shaped firmer papules (Figure 2). A 2-cm lightbrown patch was observed on the left upper arm area. There was also mild freckling around the posterior axillary folds. Punch biopsy specimens were obtained from a pedunculated papule on the neck and a dome-shaped papule on the abdomen. What is your diagnosis?
{"title":"Fleshy papules in areas of friction in a man with endocrine neoplasms.","authors":"Jennifer Walker,&nbsp;Victoria Raymond,&nbsp;Lori Lowe,&nbsp;Kelly B Cha","doi":"10.1001/archdermatol.2012.2277b","DOIUrl":"https://doi.org/10.1001/archdermatol.2012.2277b","url":null,"abstract":"A 39-year-old African American man presented with a progressive eruption of fleshy papules on his neck, axillae, groin, and abdomen. The lesions first developed on his neck in his mid-20s and slowly progressed to involve other sites. They occasionally bled when traumatized. His more recent medical history was remarkable for multigland parathyroid hyperplasia, pituitary microadenoma, and neuroendocrine pancreatic tumors. Physical examination revealed dozens of 2to 10mm, flesh-colored to brown, pedunculated, verrucous papules located circumferentially around the neck (Figure 1), extending down to the anterior aspect of the chest, and in the axillae and bilateral groin folds. Scattered across the lower area of the abdomen, there were numerous hypopigmented to flesh-colored 4to 10-mm dome-shaped firmer papules (Figure 2). A 2-cm lightbrown patch was observed on the left upper arm area. There was also mild freckling around the posterior axillary folds. Punch biopsy specimens were obtained from a pedunculated papule on the neck and a dome-shaped papule on the abdomen. What is your diagnosis?","PeriodicalId":8175,"journal":{"name":"Archives of dermatology","volume":"148 11","pages":"1317-8"},"PeriodicalIF":0.0,"publicationDate":"2012-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"31060158","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Archives of dermatology
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1